Name: U.S. panel approves COVID-19 boosters for certain high risk individuals
Uploaded: 2021-09-17T21:15:00Z
Description: The FDA advisory panel rejected a widespread administration plan for Pfizer's boosters shots, but authorized a third dose for Americans 65 and older and individuals at high risk of developing complications from COVID-19.

Loading Video…

This browser does not support the Video element.

U.S. panel approves COVID-19 boosters for certain high risk individuals

The FDA advisory panel rejected a widespread administration plan for Pfizer's boosters shots, but authorized a third dose for Americans 65 and older and individuals at high risk of developing complications from COVID-19.

Posted September 17, 2021 5:15pm EDT